ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 153

Utility of Ultrasound Synovitis Assessment As a Predictor of Flares in Clinically Inactive Joints

Tomas Cazenave1, Christian A. Waimann2, Natalia Zamora1, Gustavo Citera1 and Marcos G. Rosemffet1, 1Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 2Rheumatology, Hospital Dr. Hector Cura, Olavarria, Argentina

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: prognostic factors, Rheumatoid arthritis (RA), synovitis and ultrasonography

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Imaging of Rheumatic Diseases Poster I: Ultrasound, Optical Imaging and Capillaroscopy

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Several ultrasound (US) studies have shown a high frequency of inflammation in clinically inactive joints of rheumatoid arthritis (RA)patients. There is controversy in the conduct to be followed in these situations, raising the question of whether a change in the therapeutic approach can prevent the clinical flare of this joints. Objective:To determine the utility of US assessment of clinically inactive joints to predict short-term joint flares in patients with RA.

Methods: :A cohort study including patients with diagnosis of RA (ACR-EULAR 2010 criteria) was designed. Patients were evaluated at baseline and at 3 months, including clinical and ultrasonographic examination of 28 joints. Power Doppler (PD) signal and grayscale (GS) synovitis were graded from 0 to 3, according to standards OMERACT, yielding an overall US score (US-global) resulting from addition of both scores (range 0 -6, 6 being the highest degree of US synovitis). At baseline, the joints were classified as active vs. inactive according to clinical examination (swollen vs. non-swollen). Baseline inactive joints of patients who did not change their treatment were identified. Primary endpoint was defined as the presence of joint clinical flare (development of joint swollening in physical examination in a previously non-swollen joint) at three months follow-up. To evaluate the ability of US to predict joint flare multivariable logistic regression using the US score at baseline as the independent variable adjusted by the presence or absence of joint pain was developed. Based on the multivariate model, the area under the curve (AUC) and the probability of having a joint flare for the different levels of basal US involvement was calculated.

Results: We included a total of 49 patients. The disease duration was 8 ± 5 years, 85% were women, with a mean age of 53 ± 10 years.The mean of DAS28 was 4.8 ±  1.5. A total of 1372 joints were assessed, of which 1079 (79%) were clinically evaluated inactive. These joints showed a mean overall US score of 0.6 ± 0.8 (PD = 0.1 ± 0.3; GS = 0.5 ± 0.6). In patients without treatment variations between visits (n=24; 49%), 518 non-swollen joints at baseline were analyzed separately. Of these joints, 28 (5%) developed a flare at 3 months.  In multivariate analysis the presence of pain and the grade of US involvement at baseline were associated with greater likelihood of joint flare (OR: 3.5; 95%CI=1.1-11.4 and OR: 2; 95%CI=1.4-2.9, respectively). Figure 1shows the probability of developing joint flare at 3 months according to the US baseline score and the presence of pain. 

US Score

Probability of flare

Pain present

Pain absent

6

87%

65%

5

77%

48%

4

62%

32%

3

45%

19%

2

29%

10%

1

17%

5%

Conclusion: US evaluation could be helpful for decision-making in non-swollen joints. The likelihood of developing a flare at three months varies from 5% to 87% depending on the US findings and the presence of joint pain.


Disclosure: T. Cazenave, None; C. A. Waimann, None; N. Zamora, None; G. Citera, None; M. G. Rosemffet, None.

To cite this abstract in AMA style:

Cazenave T, Waimann CA, Zamora N, Citera G, Rosemffet MG. Utility of Ultrasound Synovitis Assessment As a Predictor of Flares in Clinically Inactive Joints [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/utility-of-ultrasound-synovitis-assessment-as-a-predictor-of-flares-in-clinically-inactive-joints/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/utility-of-ultrasound-synovitis-assessment-as-a-predictor-of-flares-in-clinically-inactive-joints/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology